RPG Investment Advisory LLC lifted its stake in Zoetis Inc (NYSE:ZTS) by 248.0% in the 1st quarter, HoldingsChannel reports. The fund owned 522 shares of the company’s stock after purchasing an additional 372 shares during the quarter. RPG Investment Advisory LLC’s holdings in Zoetis were worth $53,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in ZTS. Farmers & Merchants Trust Co of Chambersburg PA acquired a new position in Zoetis during the 1st quarter valued at about $25,000. Berman Capital Advisors LLC acquired a new position in Zoetis during the 4th quarter valued at about $26,000. Athena Capital Advisors LLC acquired a new position in Zoetis during the 4th quarter valued at about $29,000. Resources Investment Advisors Inc. acquired a new position in Zoetis during the 4th quarter valued at about $31,000. Finally, Lavaca Capital LLC acquired a new position in Zoetis during the 4th quarter valued at about $32,000. 90.93% of the stock is owned by hedge funds and other institutional investors.
Shares of ZTS stock traded down $0.41 during mid-day trading on Monday, reaching $101.26. The stock had a trading volume of 1,656,964 shares, compared to its average volume of 2,322,254. The company has a debt-to-equity ratio of 2.95, a quick ratio of 2.46 and a current ratio of 3.60. The firm has a market capitalization of $48.43 billion, a PE ratio of 32.35, a P/E/G ratio of 1.83 and a beta of 0.93. Zoetis Inc has a 1-year low of $77.00 and a 1-year high of $103.33.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 14th. The company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.53 billion. Zoetis had a return on equity of 73.85% and a net margin of 24.51%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.69 earnings per share. Sell-side analysts forecast that Zoetis Inc will post 3.46 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Stockholders of record on Thursday, April 18th will be issued a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Wednesday, April 17th. Zoetis’s dividend payout ratio is presently 21.09%.
Several research analysts recently issued reports on ZTS shares. Zacks Investment Research lowered Zoetis from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. UBS Group started coverage on Zoetis in a research report on Wednesday, January 23rd. They set a “neutral” rating and a $86.00 target price on the stock. Stifel Nicolaus raised Zoetis from a “hold” rating to a “buy” rating and upped their target price for the company from $97.00 to $110.00 in a research report on Monday, March 4th. SunTrust Banks started coverage on Zoetis in a research report on Tuesday, March 19th. They set a “hold” rating and a $100.00 target price on the stock. Finally, BMO Capital Markets upped their target price on Zoetis from $93.00 to $101.00 and gave the company a “market perform” rating in a research report on Monday, February 25th. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $100.57.
In other news, CEO Juan Ramon Alaix sold 312,109 shares of the stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $94.06, for a total value of $29,356,972.54. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Catherine A. Knupp sold 32,767 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $95.80, for a total value of $3,139,078.60. Following the completion of the transaction, the insider now directly owns 82,820 shares in the company, valued at $7,934,156. The disclosure for this sale can be found here. Insiders sold 404,209 shares of company stock worth $38,052,349 over the last three months. Corporate insiders own 0.35% of the company’s stock.
WARNING: This news story was originally posted by Macon Daily and is owned by of Macon Daily. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://macondaily.com/2019/04/15/rpg-investment-advisory-llc-buys-372-shares-of-zoetis-inc-zts.html.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Featured Story: Purposes and Functions of the Federal Reserve
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.